Phenoxypropylamines: a new series of squalene synthase inhibitors.
D000284:Administration, Oral; D000818:Animals; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology; D002784:Cholesterol / Q000096:biosynthesis; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology; D013186:Farnesyl-Diphosphate Farnesyltransferase / Q000037:antagonists & inhibitors*; D008798:Mevalonic Acid / Q000378:metabolism; D015394:Molecular Structure; D011437:Propylamines / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship
D000924:Anticholesteremic Agents; D004791:Enzyme Inhibitors; C096236:N-isopropyl-3-(4-acetylamino-2-allylphenoxy)propylamine; C096238:N-isopropyl-3-(4-amino-2-allylphenoxy)propylamine; C096237:N-isopropyl-3-(4-propionylamino-2-allylphenoxy)propylamine; D011437:Propylamines; D002784:Cholesterol; D013186:Farnesyl-Diphosphate Farnesyltransferase; D008798:Mevalonic Acid